Thursday, May 19, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home Latest News

Yale researchers may have unlocked the blood-brain barrier

March 16, 2022
in Latest News
0
Share on FacebookShare on Twitter

The brain is composed of billions of neurons—vulnerable cells that require a protective environment to function properly. This delicate environment is protected by 400 miles of specialized vasculature designed to limit which substances come into contact with the brain. This blood-brain barrier is essential for protecting the organ from toxins and pathogens. But in the context of neurological disease, the barrier “becomes your worst enemy,” says Anne Eichmann, PhD, Ensign Professor of Medicine (Cardiology) and professor of cellular and molecular physiology, as it also blocks the passage of therapeutic drugs.

For years, it has been the goal of neuroscientists and vascular biologists alike to find the magic bullet for temporarily opening and resealing the barrier for drug administration. Now, Eichmann’s team has developed an antibody as a tool for opening the blood-brain barrier for a couple of hours at a time, allowing for the delivery of drugs to a diseased brain. The team published its findings in Nature Communications on March 4.

“This is the first time we’ve figured out how to control the blood-brain barrier with a molecule,” says Eichmann, who is the senior author of the study.

The development and maintenance of the blood-brain barrier are dependent on what is called the Wnt signaling pathway, which regulates a number of crucial cellular processes. Eichmann’s team sought to figure out whether this pathway could be modulated to open the barrier “on-demand.”

When Kevin Boyé, a postdoctoral associate at Yale and first author of the study, joined Eichmann’s lab in 2017, he chose to study a molecule known as Unc5B, an endothelial membrane receptor expressed in the endothelial cells of capillaries. He found that if he knocked out this receptor in mice, they died early in their embryonic development because their vasculature failed to form properly, indicating that it was an important molecule in vascular development. He also discovered that a protein known as Claudin5—which is important for creating the tight junctions between the endothelial cells of the blood-brain barrier—was also significantly reduced. This made the team realize that the receptor could be important in maintaining this barrier.

There was previously no known link between Unc5B and the Wnt signaling pathway. Through this new study, the team figured out that the Unc5B receptor controls the pathway, functioning as an upstream regulator.

Boyé then went a step further and took the receptor out in adult mice with an already established blood-brain barrier, and found that the barrier remained open in the absence of the receptor. Next, he wanted to determine which ligands—which bind to receptors and send signals between or inside cells—were responsible for the barrier effect. He discovered that one ligand, Netrin-1, also caused a blood-barrier defect when it was removed.

Next, the team developed an antibody that could block Netrin-1 from binding to its receptor. Upon injecting the antibody, the team was able disrupt the Wnt signaling pathway, causing the blood-brain barrier to open temporarily on demand.

“It was quite a fascinating journey, especially the development of our blocking antibodies,” says Boyé. “And to see that we can open the blood-brain barrier in a very time-sensitive fashion to promote drug delivery.”

Because the blood-brain barrier blocks entry to all but a tiny subset of small molecules, neurological conditions such as Alzheimer’s, multiple sclerosis, brain tumors, and depression are exceedingly difficult to treat. Having control over the barrier will be helpful for future drug delivery ventures. The team has not yet identified any potential complications, but plans to evaluate the efficacy and potential toxicity of the antibody in later research.

“This paves the way to more interesting basic research around how the body builds such a tight barrier to protect its neurons and how can it be manipulated for drug delivery purposes,” says Eichmann. “And then there’s also potential to use this as a delivery platform for drugs to penetrate into the brain.”

In future studies, the team hopes to understand how to apply its findings to chemotherapy delivery for treating brain tumors. They are also currently working to see if they can apply their antibody to other regions of the central nervous system outside of the brain.



Journal

Nature Communications

DOI

10.1038/s41467-022-28785-9

Article Title

Endothelial Unc5B controls blood-brain barrier integrity

Article Publication Date

4-Mar-2022

Tags: barrierbloodbrainresearchersunlockedYale
Share28Tweet17Share5ShareSendShare
  • Gladstone scientists Tongcui Ma, Irene Chen, and Rahul Suryawanshi.

    “Natural immunity” from omicron is weak and limited, study finds

    68 shares
    Share 27 Tweet 17
  • Ecological functions of streams and rivers severely affected globally

    71 shares
    Share 28 Tweet 18
  • Scripps Research awarded $67 million by NIH to lead new Pandemic Preparedness Center

    66 shares
    Share 26 Tweet 17
  • Researchers discover genetic cause of megaesophagus in dogs

    1021 shares
    Share 408 Tweet 255
  • Do early therapies help very young children with or at high likelihood for autism?

    66 shares
    Share 26 Tweet 17
  • United States’ ocean conservation efforts have major gaps, Oregon State University analysis shows

    65 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Understanding how sunscreens damage coral

New Curtin research resurrects ‘lost’ coral species

SUTD develops design-based activity to enhance students’ understanding in electrochemistry

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 187 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....